Sort by
Refine Your Search
-
. Clinical studies have demonstrated that hereditary neuropathies can also involve muscle pathologies, complicate diagnosis and hamper therapy development. We have developed advanced in vitro cell models
-
. Clinical studies have demonstrated that hereditary neuropathies can also involve muscle pathologies, complicate diagnosis and hamper therapy development. We have developed advanced in vitro cell models
-
quenching dynamics. This fundamental research project will advance the understanding of photosensitizers in electrochemistry. Moreover, it will have a potential impact in novel biosensor technologies
-
team of Prof. Seppe De Schepper investigates how peripheral immune signals influence brain health and disease. We focus on tissue-resident macrophages and immune cell trafficking from periphery to brain
-
well as the available public data suggest mechanisms involving genetic, epigenetic and chromatin organisation factors governing the cell-type specific response to ARS mutations. Therefore, an integrative genome-wide cis
-
life. The successful candidate will work closely with experts in food allergy, neuroimmunology, gut physiology, and computational biology to characterize immune cell responses, construct spatial maps
-
, and poor prognosis of CRC. Adenocarcinomas also overexpress transmembrane mucins to exploit their role in promoting tumour cell death resistance. Furthermore, mucins undergo extensive splicing. Mucins
-
the imec-Vision Lab (image reconstruction, processing, and analysis), the Bio-Imaging Lab (preclinical neuro-MRI), and the Laboratory of Cell Biology and Histology (cell biology and advanced microscopy
-
towards cancer and has been linked to initiation, progression, and poor prognosis of colorectal cancer. Adenocarcinomas also overexpress transmembrane mucins to exploit their role in promoting tumour cell
-
the preparation and defence of a PhD thesis in the field of Medical Sciences. More specific, you will work on the validation of predictive peptide biomarkers to classify non-small cell lung cancer (NSCLC) patients